After secretion of anti-inflammatory cytokines by M1 TAMs at the site of injury, M2 TAMs can be recruited to the primary tumor site, where type 2 ILC and TH2 reaction products such as interleukin (IL)-4 and IL-13 are present. Here, IL4 is linked to neoplasm.